Breast Reconstruction Market

Breast Reconstruction Market Is Expected To Be Flourished By Rising Number Of Breast Cancer Cases


The global breast reconstruction market is highly concentrated on providing procedures and implantable prostheses for women who have undergone mastectomies. Breast reconstruction aims to restore symmetry, proportion and femininity by rebuilding the shape and size of the breast. This is often accomplished through the use of breast implants placed under the chest muscle or by transferring tissue from other parts of the body. With rising breast cancer incidence rates, the demand for breast reconstructive options has increased over the years.

The global breast reconstruction market is estimated to be valued at US$ 901.3 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

Rising number of breast cancer cases is expected to drive the global breast reconstruction market growth over the forecast period. According to the World Cancer Research Fund International, breast cancer is the most commonly occurring cancer in women worldwide with an estimated 2.3 million new cases diagnosed in 2020. Additionally, breast cancer awareness campaigns have helped many women understand the importance of reconstruction post mastectomy and boosted the uptake of breast reconstruction procedures globally. Another major driver fueling the market growth is the introduction of advanced breast reconstruction approaches like 3D planning software and bioengineered tissue matrices that offer natural appearance with reduced scarring. However, higher costs associated with reconstruction surgeries and prolonged recovery time remain key challenges.

Segment Analysis
The global breast reconstruction market is dominated by the implant sub-segment, which accounts for more than 60% market share. This is because breast implants are the most commonly used and recognized technique for breast reconstruction. Implant procedures such as breast augmentation and breast lifts are gaining popularity globally.

PEST Analysis
Political: Governments across various countries are increasing funding for breast cancer treatment which is positively impacting the breast reconstruction market. Supportive regulations for breast reconstruction procedures have increased the adoption.
Economic: Rising healthcare expenditure and growing focus on aesthetics are driving the demand. The growing middle-class population with higher disposable income are majorly contributing to market growth.
Social: Increasing awareness about breast reconstruction options after mastectomy or lumpectomy is a key factor. Social media influence and community support are encouraging women to undergo breast reconstruction for improved quality of life.
Technological: 3D printing, AI-assisted planning tools, short-scar techniques are some innovations revolutionizing the market. Adoption of tissue expanders and implant-based procedures over flap-based procedures due to shorter procedure time and recovery period.

Key Takeaways

The global breast reconstruction market size was valued at US$ 901.3 Mn in 2024 and is expected to witness high growth over the forecast period. The global breast reconstruction market is estimated to be valued at US$ 901.3 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030.

North America dominates the market currently due to advanced healthcare facilities and supportive reimbursement policies. The rising incidence of breast cancer cases in countries like the US and Canada is a major factor for market growth in the region. Asia Pacific is expected to witness fastest growth during the forecast period led by China, India, and Japan. Growing medical tourism coupled with rising healthcare spending in Asia Pacific countries is contributing to market growth.

Key players operating in the breast reconstruction market are Polytech Health & Aesthetics GmbH, Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra Inc., GC Aesthetics, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe. Allergan and Johnson & Johnson together account for over 60% of the market share currently due to their strong brand value and widespread product portfolio. The market is highly competitive with these players focusing on new product launches and strategic collaborations to strengthen their market position.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it